Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Grassi

Showing results (111-120 of 808) with videos related to

Pageof 81
Sort By:
Journal of Hypertension|July 17, 2004
Central sympatholytic drugs for the treatment of hypertension: back to the future?Martin Hausberg, Guido Grassi
Journal of Hypertension|April 13, 2004
Is it the the renin-angiotensin-aldosterone blockade a comprehensive tool for the management of cardiovascular risk?Claudio Borghi, Guido Grassi
Journal of Hypertension|January 11, 2013
Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertensionBrent Egan, Guido Grassi
Journal of Hypertension|May 11, 2012
Sometimes you simply have to wait: sympathetic activity in women with hypertensive pregnanciesJens Jordan, Guido Grassi
Journal of Hypertension|December 7, 2005
Autonomic imbalance and metabolic syndrome: unravelling interactions, mechanisms and outcomesGuido Grassi, Gino Seravalle
Journal of Hypertension|August 13, 2002
Systolic and diastolic blood pressure control in antihypertensive drug trialsGiuseppe Mancia, Guido Grassi
Journal of Hypertension|April 26, 2003
Reduced sympathetic cardiovascular drive in young adults with low birth weight: an interesting observation of unknown significanceUrs Scherrer, Guido Grassi
Journal of Hypertension|July 16, 2008
Flow-mediated dilatation as a biomarker for cardiovascular risk in hypertensionAlberto Avolio, Guido Grassi
Journal of Hypertension|December 4, 2008
Cardiometabolic risk in high-normal blood pressure state: mechanistic insightsGuido Grassi, Giuseppe Mancia
Journal of Hypertension|May 15, 2010
Belly fat and resistant hypertensionJens Jordan, Guido Grassi
Pageof 81

Showing results (111-120 of 808) with videos related to

Sort By:
Pageof 81
Journal of Hypertension|July 17, 2004
Central sympatholytic drugs for the treatment of hypertension: back to the future?Martin Hausberg, Guido Grassi
Journal of Hypertension|April 13, 2004
Is it the the renin-angiotensin-aldosterone blockade a comprehensive tool for the management of cardiovascular risk?Claudio Borghi, Guido Grassi
Journal of Hypertension|January 11, 2013
Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertensionBrent Egan, Guido Grassi
Journal of Hypertension|May 11, 2012
Sometimes you simply have to wait: sympathetic activity in women with hypertensive pregnanciesJens Jordan, Guido Grassi
Journal of Hypertension|December 7, 2005
Autonomic imbalance and metabolic syndrome: unravelling interactions, mechanisms and outcomesGuido Grassi, Gino Seravalle
Journal of Hypertension|August 13, 2002
Systolic and diastolic blood pressure control in antihypertensive drug trialsGiuseppe Mancia, Guido Grassi
Journal of Hypertension|April 26, 2003
Reduced sympathetic cardiovascular drive in young adults with low birth weight: an interesting observation of unknown significanceUrs Scherrer, Guido Grassi
Journal of Hypertension|July 16, 2008
Flow-mediated dilatation as a biomarker for cardiovascular risk in hypertensionAlberto Avolio, Guido Grassi
Journal of Hypertension|December 4, 2008
Cardiometabolic risk in high-normal blood pressure state: mechanistic insightsGuido Grassi, Giuseppe Mancia
Journal of Hypertension|May 15, 2010
Belly fat and resistant hypertensionJens Jordan, Guido Grassi
Pageof 81